SynthesisBMC geriatrics2026
Mapping the global landscape of behavioral interventions for sarcopenia in older adults: implications for clinical practice and research prioritization.
Synthesis in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
rationaleSarcopenia is a significant health challenge for older adults. Behavioral interventions offer promising, accessible strategies, but the evidence base requires a comprehensive assessment. AIMS AND
objectivesThis study aimed to map the global landscape of clinical trials on behavioral interventions for sarcopenia, analyzing trial characteristics, geographic trends, and the translation of completed trials into publications.
methodsA systematic review of trials registered on ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform (ICTRP) was conducted for trials registered up to 1 September 2024. Trials investigating non-pharmacological behavioral strategies for sarcopenia in adults ≥ 60 years were included. Data on design, sponsorship, location, and publication status were extracted and analyzed.
resultsAmong 171 identified trials, exercise training dominated (67.8%), with multicomponent and resistance training being the primary subtypes. Trials were concentrated in Asia (45.0%) and Europe (21.6%). Most were sponsored by academia (59.1%), enrolled ≤ 100 participants (73.1%), and used randomized designs (84.8%). Only 27 of 52 completed trials (51.9%) were published, with a median publication time of 14.5 months. The cumulative publication rate was 51.9% at 3 years post-completion.
conclusionThe research landscape is active but exhibits a pronounced focus on exercise, underrepresentation of other behavioral strategies, and significant delays in result dissemination. Coordinated efforts are needed to diversify interventions, ensure global representativeness, and improve the timely publication of findings to inform clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.